Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 May 31;53(6):3201-6.
doi: 10.1167/iovs.12-9469.

Association of vision loss in glaucoma and age-related macular degeneration with IADL disability

Affiliations
Comparative Study

Association of vision loss in glaucoma and age-related macular degeneration with IADL disability

Chad Hochberg et al. Invest Ophthalmol Vis Sci. .

Abstract

Purpose: To determine if glaucoma and/or age-related macular degeneration (AMD) are associated with disability in instrumental activities of daily living (IADLs).

Methods: Glaucoma subjects (n = 84) with bilateral visual field (VF) loss and AMD subjects (n = 47) with bilateral or severe unilateral visual acuity (VA) loss were compared with 60 subjects with normal vision (controls). Subjects completed a standard IADL disability questionnaire, with disability defined as an inability to perform one or more IADLs unassisted.

Results: Disability in one or more IADLs was present in 18.3% of controls as compared with 25.0% of glaucoma subjects (P = 0.34) and 44.7% of AMD subjects (P = 0.003). The specific IADL disabilities occurring more frequently in both AMD and glaucoma subjects were preparing meals, grocery shopping, and out-of-home travelling (P < 0.05 for both). In multivariate logistic regression models run adjusting for age, sex, mental status, comorbidity, and years of education, AMD (odds ratio [OR] = 3.4, P = 0.02) but not glaucoma (OR = 1.4, P = 0.45) was associated with IADL disability. However, among glaucoma and control patients, the odds of IADL disability increased 1.6-fold with every 5 dB of VF loss in the better-seeing eye (P = 0.001). Additionally, severe glaucoma subjects (better-eye MD worse than -13.5 dB) had higher odds of IADL disability (OR = 4.2, P = 0.02). Among AMD and control subjects, every Early Treatment of Diabetic Retinopathy Study line of worse acuity was associated with a greater likelihood of IADL disability (OR = 1.3).

Conclusions: VA loss in AMD and severe VF loss in glaucoma are associated with self-reported difficulties with IADLs. These limitations become more likely with increasing magnitude of VA or VF loss.

PubMed Disclaimer

Conflict of interest statement

Disclosure: C. Hochberg, None; E. Maul, None; E.S. Chan, None; S. Van Landingham, None; L. Ferrucci, None; D.S. Friedman, None; P.Y. Ramulu, None

Figures

Figure 1.
Figure 1.
Association of IADL disability with disease severity. Mean better-eye MD was +0.2 dB (IQR = −0.6 to +0.9 dB) in controls (n = 60), −3.8 dB (IQR = −4.8 to −3.2 dB) in the mild glaucoma group (n = 28), −8.0 dB (IQR = −11.1 to −6.9 dB) in the moderate glaucoma group (n = 28), and −19.5 dB (IQR = −16.7 to −25.5 dB) in the severe glaucoma group (n = 28). Mean logMAR better-eye VA was +0.08 (IQR = 0 to +0.16) for controls (n = 60), 0.18 (IQR = 0.1 to 0.28) for the better VA AMD group (n = 23) and 0.65 (IQR = 0.52 to 0.76) for the worse VA AMD group (n = 24). *OR = 4.2 (95% CI 1.3 – 13.9) vs. controls after adjustment for health and demographic covariates. **OR = 3.7 (95% CI 1.1 – 13.0) vs. controls after adjustment for health and demographic covariates.
Figure 2.
Figure 2.
Modeled probability of IADL disability by severity of vision loss. Circles reflect outcomes for individual patients, who either had IADL disability (probability = 1) or did not have IADL disability (probability = 0). Models reflect probability adjusted for age, education, sex, comorbidity, and MMSE score. *Glaucoma and control subjects only. **AMD and control subjects only.

References

    1. Quigley HA, Broman T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophtalmol. 2006;90:262–267 - PMC - PubMed
    1. Friedman DS, O'Colmain BJ, Muñoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophtalmol. 2004;122:564–572 - PubMed
    1. Ramulu PY. Glaucoma and disability: which tasks are affected, and at what stage of disease?. Curr Opin Ophtalmol. 2009;20:92 - PMC - PubMed
    1. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophtalmol. 2001;119:1050–1058 - PubMed
    1. Jampel HD, Schwartz A, Pollack I, et al. Glaucoma patients' assessment of their visual function and quality of life. J Glaucoma. 2002;11:154–163 - PubMed

Publication types